PFE logo

Pfizer (PFE) Interest Expense

Annual Interest Expense

$2.21 B
+$971.00 M+78.43%

31 December 2023

PFE Interest Expense Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Interest Expense

$783.00 M
+$5.00 M+0.64%

30 September 2024

PFE Quarterly Interest Expense Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM Interest Expense

$3.04 B
+$88.00 M+2.98%

30 September 2024

PFE TTM Interest Expense Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PFE Interest Expense Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+78.4%+12.7%+65.7%
3 y3 years+52.5%+140.9%+129.5%
5 y5 years+67.9%+91.4%+98.8%

PFE Interest Expense High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 yearsat high+78.4%-0.9%+167.2%at high+146.1%
5 y5 yearsat high+78.4%-0.9%+167.2%at high+146.1%
alltimeall timeat high+328.1%-0.9%+181.7%at high+723.6%

Pfizer Interest Expense History

DateAnnualQuarterlyTTM
Sept 2024
-
$783.00 M(+0.6%)
$3.04 B(+3.0%)
June 2024
-
$778.00 M(-1.5%)
$2.95 B(+10.1%)
Mar 2024
-
$790.00 M(+14.8%)
$2.68 B(+21.4%)
Dec 2023
$2.21 B(+78.4%)
$688.00 M(-1.0%)
$2.21 B(+20.4%)
Sept 2023
-
$695.00 M(+36.8%)
$1.83 B(+26.5%)
June 2023
-
$508.00 M(+59.7%)
$1.45 B(+17.4%)
Mar 2023
-
$318.00 M(+1.6%)
$1.24 B(-0.3%)
Dec 2022
$1.24 B(-4.1%)
$313.00 M(+0.6%)
$1.24 B(-0.2%)
Sept 2022
-
$311.00 M(+6.1%)
$1.24 B(-1.1%)
June 2022
-
$293.00 M(-9.0%)
$1.26 B(-1.8%)
Mar 2022
-
$322.00 M(+1.9%)
$1.28 B(-1.1%)
Dec 2021
$1.29 B(-10.9%)
$316.00 M(-2.8%)
$1.29 B(-2.3%)
Sept 2021
-
$325.00 M(+2.8%)
$1.32 B(-1.5%)
June 2021
-
$316.00 M(-6.0%)
$1.34 B(-3.7%)
Mar 2021
-
$336.00 M(-3.2%)
$1.40 B(-3.7%)
Dec 2020
$1.45 B(-7.9%)
$347.00 M(+0.6%)
$1.45 B(-4.5%)
Sept 2020
-
$345.00 M(-6.0%)
$1.52 B(-4.0%)
June 2020
-
$367.00 M(-5.9%)
$1.58 B(-1.4%)
Mar 2020
-
$390.00 M(-6.0%)
$1.60 B(+1.8%)
Dec 2019
$1.57 B(+19.5%)
$415.00 M(+1.5%)
$1.57 B(+2.9%)
Sept 2019
-
$409.00 M(+5.1%)
$1.53 B(+6.9%)
June 2019
-
$389.00 M(+7.8%)
$1.43 B(+4.6%)
Mar 2019
-
$361.00 M(-2.4%)
$1.37 B(+3.9%)
Dec 2018
$1.32 B(+3.6%)
$370.00 M(+19.4%)
$1.32 B(+3.1%)
Sept 2018
-
$310.00 M(-4.9%)
$1.28 B(-0.8%)
June 2018
-
$326.00 M(+5.2%)
$1.29 B(+1.1%)
Mar 2018
-
$310.00 M(-6.1%)
$1.27 B(+0.1%)
Dec 2017
$1.27 B(+7.1%)
$330.00 M(+3.1%)
$1.27 B(+2.7%)
Sept 2017
-
$320.00 M(+2.6%)
$1.24 B(+2.4%)
June 2017
-
$312.00 M(+1.0%)
$1.21 B(+1.7%)
Mar 2017
-
$309.00 M(+4.0%)
$1.19 B(+0.3%)
DateAnnualQuarterlyTTM
Dec 2016
$1.19 B(-1.1%)
$297.00 M(+2.1%)
$1.19 B(-3.1%)
Sept 2016
-
$291.00 M(-0.3%)
$1.22 B(+1.1%)
June 2016
-
$292.00 M(-4.6%)
$1.21 B(+1.2%)
Mar 2016
-
$306.00 M(-8.7%)
$1.20 B(-0.3%)
Dec 2015
$1.20 B(-11.8%)
$335.00 M(+20.5%)
$1.20 B(-1.5%)
Sept 2015
-
$278.00 M(0.0%)
$1.22 B(-5.1%)
June 2015
-
$278.00 M(-10.0%)
$1.28 B(-4.8%)
Mar 2015
-
$309.00 M(-12.5%)
$1.35 B(-0.9%)
Dec 2014
$1.36 B(-3.8%)
$353.00 M(+2.9%)
$1.36 B(+0.4%)
Sept 2014
-
$343.00 M(0.0%)
$1.35 B(+0.2%)
June 2014
-
$343.00 M(+6.9%)
$1.35 B(-1.0%)
Mar 2014
-
$321.00 M(-7.5%)
$1.36 B(-3.5%)
Dec 2013
$1.41 B(-7.1%)
$347.00 M(+2.1%)
$1.41 B(-1.8%)
Sept 2013
-
$340.00 M(-4.5%)
$1.44 B(-2.8%)
June 2013
-
$356.00 M(-4.0%)
$1.48 B(-1.5%)
Mar 2013
-
$371.00 M(-0.5%)
$1.50 B(-1.2%)
Dec 2012
$1.52 B(-9.5%)
$373.00 M(-2.1%)
$1.52 B(-1.5%)
Sept 2012
-
$381.00 M(+0.8%)
$1.54 B(-2.6%)
June 2012
-
$378.00 M(-3.1%)
$1.59 B(+6.1%)
Mar 2012
-
$390.00 M(-1.5%)
$1.50 B(-4.3%)
Dec 2011
$1.68 B(-6.5%)
$396.00 M(-6.4%)
$1.56 B(-3.9%)
Sept 2011
-
$423.00 M(+47.4%)
$1.63 B(-0.2%)
June 2011
-
$287.00 M(-37.3%)
$1.63 B(-5.9%)
Mar 2011
-
$458.00 M(-0.2%)
$1.73 B(-3.6%)
Dec 2010
$1.80 B(+45.7%)
$459.00 M(+7.5%)
$1.80 B(-0.3%)
Sept 2010
-
$427.00 M(+9.8%)
$1.80 B(+3.3%)
June 2010
-
$389.00 M(-25.5%)
$1.74 B(+28.7%)
Mar 2010
-
$522.00 M(+12.5%)
$1.35 B(+62.7%)
Dec 2009
$1.23 B(+139.0%)
$464.00 M(+25.7%)
$833.00 M(+125.7%)
Sept 2009
-
$369.00 M
$369.00 M
Dec 2008
$516.00 M
-
-

FAQ

  • What is Pfizer annual interest expense?
  • What is the all time high annual interest expense for Pfizer?
  • What is Pfizer annual interest expense year-on-year change?
  • What is Pfizer quarterly interest expense?
  • What is the all time high quarterly interest expense for Pfizer?
  • What is Pfizer quarterly interest expense year-on-year change?
  • What is Pfizer TTM interest expense?
  • What is the all time high TTM interest expense for Pfizer?
  • What is Pfizer TTM interest expense year-on-year change?

What is Pfizer annual interest expense?

The current annual interest expense of PFE is $2.21 B

What is the all time high annual interest expense for Pfizer?

Pfizer all-time high annual interest expense is $2.21 B

What is Pfizer annual interest expense year-on-year change?

Over the past year, PFE annual interest expense has changed by +$971.00 M (+78.43%)

What is Pfizer quarterly interest expense?

The current quarterly interest expense of PFE is $783.00 M

What is the all time high quarterly interest expense for Pfizer?

Pfizer all-time high quarterly interest expense is $790.00 M

What is Pfizer quarterly interest expense year-on-year change?

Over the past year, PFE quarterly interest expense has changed by +$88.00 M (+12.66%)

What is Pfizer TTM interest expense?

The current TTM interest expense of PFE is $3.04 B

What is the all time high TTM interest expense for Pfizer?

Pfizer all-time high TTM interest expense is $3.04 B

What is Pfizer TTM interest expense year-on-year change?

Over the past year, PFE TTM interest expense has changed by +$1.21 B (+65.70%)